General Updates

27th July, 2026 The Dy. General Manager (Listing Dept.) The Manager – Listing Dept., BSE Limited, National Stock Exchange of India Limited Corporate Relationship Dept., Exchange Plaza, 5th Floor, 1st Floor, New Trading Ring, Plot No. C/1, G. Block, P. J. Towers, Dalal Street, Fort, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai - 400 051 (BSE Scrip Code: 500420) (NSE Symbol: TORNTPHARM) Dear Sir/ Madam, Sub.: Receipt of Final Listing and Trading Approval for 4,19,22,416 fully paid-up Equity shares of the Company issued and allotted in terms of Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited (“Transferor Company” or “JB Chemicals”) with Torrent Pharmaceuticals Limited (“Company” or “Transferor Company” or “Torrent Pharma”) and their respective shareholders (“Scheme”) Ref.: Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ==================================================================== This is further to our earlier intimation dated 20th July, 2026 intimating about the allotment of 4,19,22,416 Equity Shares of ₹ 5/- each to eligible Shareholders of JB Chemicals as on the Record Date i.e. Friday, 17th July, 2026, pursuant to the Scheme. We wish to inform you that the Company has received Final Listing and Trading Approval for aforesaid Equity Shares from National Stock Exchange of India Limited (“NSE”) and BSE Limited (“BSE”) on 27th July, 2026. The aforesaid Equity Shares of the Company are being listed and admitted to dealings on the Exchanges (i.e. NSE and BSE) w.e.f. 28th July, 2026. Email – investorservices@torrentpharma.com Kindly take the same on record. Thanking you. Yours sincerely, For TORRENT PHARMACEUTICALS LIMITED CHINTAN M. TRIVEDI COMPANY SECRETARY Email – investorservices@torrentpharma.com